Identification of nonessential regions of the nsp2 protein of an attenuated vaccine strain (HuN4-F112) of highly pathogenic porcine reproductive and respiratory syndrome virus for replication in marc-145 cell by Yan-Zhao Xu et al.
Xu et al. Virology Journal 2012, 9:141
http://www.virologyj.com/content/9/1/141SHORT REPORT Open AccessIdentification of nonessential regions of the
nsp2 protein of an attenuated vaccine strain
(HuN4-F112) of highly pathogenic porcine
reproductive and respiratory syndrome virus for
replication in marc-145 cell
Yan-Zhao Xu, Yan-Jun Zhou, Shan-Rui Zhang, Wu Tong, Ling Li, Yi-Feng Jiang and Guang-Zhi Tong*Abstract
Background: The regions in the middle of nonstructural protein 2 (nsp2) of porcine reproductive and respiratory
syndrome virus (PRRSV) have been shown to be nonessential for PRRSV replication, and these nonessential regions
are different in various viral strains.
Finding: In this study, the nonessential regions of the nsp2 of an attenuated vaccine strain (HuN4-F112) of highly
pathogenic porcine reproductive and respiratory syndrome virus were identified based on an infectious cDNA
clone of HuN4-F112. The results demonstrated that the segments of nsp2 [amino acids (aa) 480 to 667] tolerated
deletions. Characterization of the mutants demonstrated that those with small deletions did not affect the viral
growth on Marc-145 cells, but deletion of these regions led to earlier PRRSV replication increased (before 36 h after
infectious in vitro).
Conclusion: The functional roles of nsp2 variable middle region for PRRSV HuN4-F112 replication have been
identified. Our results also suggested that none-essential region might be an ideal insertion region to express
foreign gene in PRRSV genome.
Keywords: HuN4-F112, Nsp2, Nonessential region, Deletion mutantFinding
Porcine reproductive and respiratory syndrome virus
(PRRSV) is an enveloped, positive-stranded RNA virus
belonging to the family Arteriviridae [1]. Based on a dif-
ference in nucleotide sequence, two PRRSV genotypes
have been identified including European genotype (type
1) and North American genotype (type 2) represented
by prototype viruses Lelystad and VR-2332, respectively
[2-5]. The genome of PRRSV is approximately 15 kb in
size, and it contains ten open reading frames (ORF),
designated as ORF1a, ORF1b, ORF2a, ORF2b, and ORF* Correspondence: gztong@shvri.ac.cn
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reproduction in any medium, provided the or3 to ORF5, ORF5a, ORF6 and ORF7 [3,6-10]. ORF1a
and ORF1b encode viral nonstructural proteins which
are directly translated upon viral entry. Then the poly-
proteins are cleaved into 14 nonstructural protein (nsp)
(nsp1α, nsp1β, nsp2 to nsp6, nsp7α, nsp7β, and nsp8 to
nsp12) that participate viral replication and transcrip-
tion. Among the 14 nonstructural proteins, the nsp2
protein is the largest PRRSV replicative protein
[2,11,12]. Through the alignment of arterivirus nsp2 pro-
teins, nsp2 could be recognized containing three major
domains: a N-terminal cysteine proteinase domain
(PL2), a middle region, and a hydrophobic transmem-
brane (TM) region close to the C terminus [11,13-15].
Nsp2 has been shown to be highly heterogeneous and
variable, and become a key factor in distinguishingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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length difference and less than 40% similarity of their
amino acid sequences [2,4,16].
It was reported that natural mutations, insertions, or
deletions always occurred in the middle region or near
to the N-terminal region of the nsp2, while the putative
PL2 domain and TM domain remains well conserved
[2,4,13,17-22]. In 2006, a highly pathogenic porcine re-
productive and respiratory syndrome virus (HP-PRRSV)
(a virulent form of PRRSV, i.e., HP-PRRSV HuN4) was
identified in China [21,23,24]. HuN4-F112 was an atte-
nuated strain by passaging the HP-PRRSV HuN4 on
Marc-145 cell in our laboratory [25]. One character of
the virulent PRRSV strain was two discontinuous dele-
tions of 1 aa and 29 aa at positions 482 and 534–562, re-
spectively, relative VR-2332 [21,26]. So in our study, we
wanted to explore the genetic flexibility of the virulent
form of PRRSV nsp2 protein and identified the nones-
sential regions in the middle of nsp2 of HP-PRRSV
Strain HuN4-F112.
Full-length cDNA clone of HuN4-F112 was con-
structed as shown in Figure 1 as according to Zhang
et al. [27]. The cDNA clone (pSK-F112) contains the
SP6 RNA polymerase promoter at the 5′-end of PRRSV
genome, the 3′-end sequence flanked the 32 poly (A),
and a MluI restriction enzyme site at nt 14667 which
was a genetic marker to differentiate the rescued viruses
and parental virus (HuN4-F112).Figure 1 Assembly of the full-length cDNA clone of PRRSV strain HuN
Each of these fragments was cloned to pSK vector with unique restriction
into pSK, respectively. Finally, the full-length clone was assembled from pSK
and genetic marker (MluI enzyme cleavage sites at 14667nt) were added b
PRRSV strain HuN4-F112.The nsp2 deletion strains were generated by the Quick
Change Multi site-directed mutagenesis kit (Stratagene)
according to the manufacturer’s recommendations. The
deletion regions of nsp2 were showed in Figure 2.
Sequences of deletion primers were listed in Table 1.
The construction of the deletion full-length cDNA clone
was performed in two steps. First, the deletion fragments
ABC (named pSK-ABC-Δ) were created by mutagenesis
kit. Then, the deletion full-length infectious clones were
assembled by ligating fragments DEF with pSK-ABC-Δ
as shown on Figure 1.
To rescue these infectious cDNA clones in vitro, tran-
scription and transfection of the full length viral cDNA
clones were performed according to the manufacturer’s
instructions. Briefly, the full-length cDNA clone was lin-
earized by cleavage with restriction enzyme SwaI, which
cuts downstream of the poly (A) tail. Then, the capped
RNA transcripts from cDNA were performed using the
mMESSAGE MACHINE SP6 kit (Ambion, USA). Subse-
quently, the in vitro transcribed RNA was transfected
into BHK-21 cells using DMRIE-C reagent (Invitrogen,
USA). To rescue the virus, cell culture supernatant
obtained 24 h post-transfection was serially passaged on
Marc-145 cells. The infected Marc-145 cells were moni-
tored daily for the formation of CPE (cytopathic effect).
The successfully recovered recombinant viruses were
tested as below. The nsp2 mutant regions of the recom-
binant viruses were examined by RT-PCR (Reverse4-F112. The total genome was amplified in six fragments (A to E).
enzyme cleavage site, respectively. Then, A-B-C and D-E-F were linked
-ABC and pSK-DEF with PacI and ClaI . A SP6 polymerase promoter
y PCR. Arrowheads and numbers indicate enzyme cleavage sites in
Figure 2 Construction of PRRSV strain HuN4-F112 nsp2 mutants. Mutagenesis PCR was used to delete and insert fragment in the nsp2
region. The deleted amino acids are shown as thin dashed lines, thick dashed lines indicate the sequence naturally deleted as compared with the
North American genotype representative virus VR-2332. The putative enzyme domain (PL2) and TM region are indicated in the figure. The
viability for each mutant constructed is shown on the right: +, viable; -, nonviable.
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sages in Marc-145 cells. Two pairs of primers were used
to identify each mutant virus: one (F2436/R3442) target-





















R14752targeting the mutant MluI restriction enzyme site. As
shown in Figure 3A, all the successfully recovered mu-
tant viruses maintained the respective engineered dele-





















Figure 3 Identification of the rescued viruses by RT-PCR. One pair of primers (F2436/R3442) amplifying deletion region of the nsp2 was used
to confirm the presence of deletions (A). Another pair of primers (R14320/F14752) amplifying part of PRRSV was used to identify the recombinant
viruses containing a MluI enzyme site as gene marker, The results of RT-PCR products digested by MluI indicated that the recombinant viruses
were rescued from cDNA clones (B).
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tested (Figure 3B), and these regions were also
sequenced (at least 10 clones) (data not shown). Subse-
quently, the successfully recovered viruses were test by
immunofluorescence assay (IFA). Marc-145 cells grown
on 6-well plates and infected with virus were fixed in
80% cold ethanol at 4°C for 30 min. The cells were incu-
bated for 60 min with PRRSV nucleocapsid protein
monoclone antibody and nsp4 protein monoclone anti-
body, respectively, and then stained with lexa FluorW568
goat anti-mouse lg G (H+L) (Invitrogen, USA) and
examined by fluorescence microscopy. The images were
collected under an Olympus IX-70 inverted microscope
(Figure 4). The results showed that all the successfully
recovered viruses could be detected by antibody of the
nsp4 and N protein of PRRSV.Figure 4 Identification of the deletion or insertion viruses by IFA test
rHuN4-F112-Δ 480-532, rHuN4-F112-Δ 508-532, rHuN4-F112-Δ 480-620 rHuN
after infection, cells were processed for indirect immunofluorescence after
protein (Anti-nsp4 Ab). As expected, the Ab specific for NP protein and nspTo determine the effect of the nsp2 deletions on
PRRSV growth, the ability to form plaques was exam-
ined. Confluent monolayers of Marc-145 cells cultured
in a 6-well plate were infected with 10-fold serially
diluted viruses (10 to 0.001 TCID50). After 1 h incuba-
tion, the excessive inoculum was removed and an agar
overlay was applied onto the monolayer. Plaques were
stained at 37 °C with crystal violet 5 days post infection.
The results showed that the plaque sizes of the deletion
viruses had no significant difference in comparison to
that of parental virus HuN4-F112 (Figure 5).
Viral growth assays was finished as the papers
reported. The titers of PRRSV were all expressed as
TCID50. Marc-145 cell monolayer in T-25 flasks was
infected with either parental or mutant viruses at
100TCID50. After 1 h of attachment at 37°C in 5% CO2. Marc-145 cells were infected with the five passages deletion viruses,
4-F112-Δ 480-667 and parental virus rHuN4-F112. Approximately 24 h
incubation with Abs specific for PRRSV NP protein (Anti-NP Ab), nsp4
4 protein could react with all these 5 recovery viruses.
Figure 5 Plaque assays for parental HuN4-F112, rHuN4-F112, rHuN4-F112-Δ480-532, rHuN4-F112-Δ508-532, rHuN4-F112-Δ480-620,
and rHuN4-F112-Δ480-667 were completed in parallel. MARC-145 cells were infected with viruses, and monolayer was stained with crystal
violet at 5 days post infection.
Figure 6 Viral growth curve analysis. Marc-145 cells in T-25
flasks were infected with PRRSV nsp2 small deletion mutants
and parental virus at 100TCID50. The cell supernatants were
collected for titration analysis by the method of Reed-Muench at
every 12 h hpi. The virus was titrated on Marc-145 cells.
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removed and the monolayer was washed three times
with serum-free DMEM. After washing, 5 ml 2% FBS
DMEM was added and the flasks were then incubated
for up to 4 days at 37°C in 5% CO2. Samples were col-
lected from the medium at every 12 hours post infection
(hpi) and titrated by the method of Reed-Muench on
Marc-145 cells in 96-well plates. The results of the viral
growth curve analysis (Figure 6) showed that nsp2 with
small deletions did not affect the viral growth on Marc-
145 cells, but the titers of the deletion virus were higher
than the parental virus during the early stage of infection
(before 36 h). The titers of the rHuN4-F112-Δ480-532,
rHuN4-F112-Δ508-532, and rHuN4- F112-Δ480-667 be-
fore 36 h were about 1000-fold higher than that of the
parental virus HuN4-F112, and the titers of the rHuN4-
F112-Δ480-620 before 36 h were about 100-fold higher
than that of the parental virus HuN4-F112.
In this study, eight deletion constructs were pro-
duced as shown in Figure 2: rHuN4-F112-Δ480-532,
rHuN4-F112-Δ508-532, rHuN4-F112-Δ480-620, rHuN4-
F112-Δ480-667, rHuN4-F112-Δ420-532, rHuN4-F112-
Δ400-532, rHuN4-F112- Δ444-667, and rHuN4-F112-
Δ400-700. The transfection results suggested that four
mutants (rHuN4-F112-Δ480-532, rHuN4-F112-Δ508-
532, rHuN4-F112-Δ480-620, and rHuN4-F112-Δ480-
667) resulted in viable viruses. All others produced
nonreplicating PRRSV genomes, and the deletion cDNA
clones appeared to be lethal to the virus, which havebeen rescued at least five clones. Recently, Han J et al.
reported that deletion aa 324 to 746 of nsp2 of PRRSV
VR-2332 strain did not affect the viral replication, and
they also found that the mutant virus displayed
decreased cytolytic activity on Marc-145 cell and did
not develop visible plaques [15]. The combined data
showed that HuN4-F112 nsp2 harbors smaller nones-
sential region for viral replication than VR-2332 strain
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2332 have different length and share less than 70%
similarity of their amino acid, and this may be the rea-
son why the nonessential regions is different among the
different PRRSV strains.
Although deletions of the segments of nsp2 [amino
acids (aa) 480 to 667] did not affect the viral growth on
Marc-145 cells, deletion of these regions led to earlier
PRRSV replication increased (before 36 h after infectious
in vitro), which suggested that the sequences of the non-
essential regions of nsp2 might play an important role in
regulating the viral replication through an unknown
mechanism. Recently, nsp1, nsp2, nsp4 and nsp11 were
found to have strong ability to moderate inhibitory
effects on beta interferon (IFN-β) promoter activation to
regulate host innate immune response, but the roles of
the nsp4 were not clear [28]. Therefore, the function of
these nonessential sequences of nsp2 should be under
investigated.
PRRSV as a potential viral vector has been investigated
previously. Most of the concern was focused on the region
between the ORFs and the 3′ end of the genome [29-31],
while recently some researchers were interested in using
nsp2 to express foreign gene since the nonessential regions
of nsp2 for replication had been identified [15,32-34].
When viral structural proteins were used to express the for-
eign genes, the size of the insertion was limited to less than
10 amino acids [29]. Inserting the fragment into the in-
ternal ORFs would affect the PRRSV replication. Therefore,
the nonessential region of PRRSV nsp2 suggested the likeli-
hood of expressing a large foreign gene as a fusion protein
in the viral replicase region. Therefore, these identified non-
essential regions suggested they might be the potential
inserted sites to express the foreign gene in PRRSV
genome.
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